NO964735L - Adenosin-derivater - Google Patents

Adenosin-derivater

Info

Publication number
NO964735L
NO964735L NO964735A NO964735A NO964735L NO 964735 L NO964735 L NO 964735L NO 964735 A NO964735 A NO 964735A NO 964735 A NO964735 A NO 964735A NO 964735 L NO964735 L NO 964735L
Authority
NO
Norway
Prior art keywords
compounds
formula
alkyl
adenosine derivatives
cycloalkyl
Prior art date
Application number
NO964735A
Other languages
English (en)
Other versions
NO964735D0 (no
Inventor
Fulvio Gadient
Bonnie L K Mangold
John R Fozard
Mahavir Prashad
Prasad Koteswara Kapa
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9409324A external-priority patent/GB9409324D0/en
Priority claimed from GB9416693A external-priority patent/GB9416693D0/en
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of NO964735D0 publication Critical patent/NO964735D0/no
Publication of NO964735L publication Critical patent/NO964735L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Abstract

Forbindelser med formel I hvori R! har en rekke betydninger, inkluderende cykloalkyl og hydroksycykloalkyl, R2 er hydrogen, (C1.4)alkyl, amino, (C3_5)cykloalkyl eller halogen med et atomtall 9 til 35, og R3 er (C1.4)alkyl, og som kan anvendes som analgetiske midler. Forbindelser med formel I hvori Rx er hydroksyalkyl er nye forbindelser. Forbindelsene med formel I kan fremstilles ved alkylering i 2'-stillingen i nærvær av tetrabutylammonium- hydrogensulfat og et ikke-polart løsningsmiddel.
NO964735A 1994-05-10 1996-11-08 Adenosin-derivater NO964735L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9409324A GB9409324D0 (en) 1994-05-10 1994-05-10 New organic compounds, their preparation and use
US24991494A 1994-05-26 1994-05-26
GB9416693A GB9416693D0 (en) 1994-08-18 1994-08-18 Improvements in or relating to organic compounds
PCT/US1995/005802 WO1995030683A1 (en) 1994-05-10 1995-05-09 Adenosine derivatives

Publications (2)

Publication Number Publication Date
NO964735D0 NO964735D0 (no) 1996-11-08
NO964735L true NO964735L (no) 1997-01-10

Family

ID=27267177

Family Applications (1)

Application Number Title Priority Date Filing Date
NO964735A NO964735L (no) 1994-05-10 1996-11-08 Adenosin-derivater

Country Status (13)

Country Link
EP (1) EP0759925A1 (no)
JP (1) JPH09512823A (no)
CN (1) CN1147815A (no)
AU (1) AU2546195A (no)
BR (1) BR9507683A (no)
CA (1) CA2186847A1 (no)
CZ (1) CZ327896A3 (no)
FI (1) FI964468A0 (no)
HU (1) HUT75338A (no)
NO (1) NO964735L (no)
PL (1) PL316985A1 (no)
SK (1) SK146096A3 (no)
WO (1) WO1995030683A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6110902A (en) * 1997-06-23 2000-08-29 Moehler; Hanns Method for the inhibition of neuronal activity leading to a focal epileptic seizure by local delivery of adenosine
GB0228723D0 (en) 2002-12-09 2003-01-15 Cambridge Biotechnology Ltd Treatment of pain
GB0305149D0 (en) * 2003-03-07 2003-04-09 Cambridge Biotechnology Ltd Compounds for the treatment of pain
EP2021350B1 (en) 2006-03-21 2016-12-21 Rheinische Friedrich-Wilhelms-Universität Bonn Phosphorylated a2a receptor agonists
CN108822174A (zh) * 2018-08-29 2018-11-16 上海兆维科技发展有限公司 新型核苷修饰物2’-eoe-鸟嘌呤核苷及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8729994D0 (en) * 1987-12-23 1988-02-03 Glaxo Group Ltd Chemical compounds
GB2226027B (en) * 1988-12-13 1992-05-20 Sandoz Ltd Adenosine derivatives,their production and use
US5017578A (en) * 1989-06-09 1991-05-21 Hoechst-Roussel Pharmaceuticals Inc. N-heteroaryl-purin-6-amines useful as analgesic and anticonvulsant agents
HUT61567A (en) * 1990-12-07 1993-01-28 Sandoz Ag Process for producing new pharmaceutical compositions comprising 2'-o-alkyladenosine derivatives and for producing 6-cyclohexyl-2'-o-methyladenosinehydrate
DK62692D0 (no) * 1992-05-14 1992-05-14 Novo Nordisk As

Also Published As

Publication number Publication date
AU2546195A (en) 1995-11-29
FI964468A (fi) 1996-11-06
CZ327896A3 (en) 1997-03-12
EP0759925A1 (en) 1997-03-05
HUT75338A (en) 1997-05-28
SK146096A3 (en) 1997-07-09
WO1995030683A1 (en) 1995-11-16
NO964735D0 (no) 1996-11-08
BR9507683A (pt) 1997-09-23
JPH09512823A (ja) 1997-12-22
HU9603105D0 (en) 1997-01-28
PL316985A1 (en) 1997-03-03
CA2186847A1 (en) 1995-11-16
CN1147815A (zh) 1997-04-16
FI964468A0 (fi) 1996-11-06

Similar Documents

Publication Publication Date Title
CA2396738A1 (en) Thiazole derivatives as active superoxide radical inhibitors
YU40997A (sh) Novi oksadiazoli, postupci za njihovo pripremanje
YU11997A (sh) Laktamski derivati i njihove farmaceutske kompozicije
MEP24608A (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
ATE242625T1 (de) Chelat-zubereitungen, die oximverbindungen enthalten
PT97888A (pt) Processo para a preparacao de compostos heterociclicos derivados de indol e de composicoes farmaceuticas que os contem
FI924569A (fi) Foerfarande foer enantioselektiv framstaellning av fenylisoserinderivat
EP0531548A4 (en) Remedy for thrombosis and phosphodiesterase inhibitor
ES2105108T3 (es) Esteroides para el tratamiento de la hipertrofia prostatica, su preparacion y su utilizacion.
NO911158L (no) Hydantoinderivater.
ATE102196T1 (de) Glykosidase-inhibitor salbostatin, verfahren zu seiner herstellung und seine verwendung.
DE69728544D1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
ATE285410T1 (de) Naphthyridinderivate oder salze davon
ATE158795T1 (de) Thiazolidindionderivate, ihre herstellung und anwendung
ATE266398T1 (de) Pharmazeutische zusammensetzungen enthaltend tyrphostine
NO994659L (no) Nye pyridinderivater og farmasöytiske preparater inneholdende slike
NO964735L (no) Adenosin-derivater
NO971142L (no) Bis-(2-halogenetyl)aminofenylsubstituerte distamycinderivater som antitumor- og antivirale midler
EP0757987A4 (en) PYRAZOLECARBOXYLIC ACID DERIVATIVE AND PLANT DISEASE CONTROL AGENT
HUP9801133A2 (hu) 1,2,4-Triazol-származékok, továbbá ilyen vegyületeket hatóanyagként tartalmazó fungicid készítmények
ES2016017A6 (es) Procedimiento para preparar derivados de acido 1,1-dioxocefem-4-carbotiolico.
CA2011642A1 (en) Benzoxazine dyes
NO944577L (no) Hemming av effekten av amyloidogene proteiner
CA2052020A1 (en) Pradimicin derivatives
NO307139B1 (no) Fremgangmåte ved fremstilling av 5,6-dihydroksy-2-amino- 1,2,3,4-tetrahydronaftalenderivater